An update on the association of vitamin D deficiency with common infectious diseases 1 (Q22306476)

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D insufficiency may impair CD4 recovery among Women's Interagency HIV Study participants with advanced disease on HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D and the anti-viral state

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Differential Protein Pathways in 1,25-Dihydroxyvitamin D3 and Dexamethasone Modulated Tolerogenic Human Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Review of metabolic, immunologic, and virologic consequences of suboptimal vitamin D levels in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D and immune function: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

An update on vitamin D and human immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Plasma LL-37 correlates with vitamin D and is reduced in human immunodeficiency virus-1 infected individuals not receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Neuraminidase inhibitors for preventing and treating influenza in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D level and risk of community-acquired pneumonia and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Low serum 25-hydroxyvitamin D level: an independent risk factor for tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D in HIV-Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Autophagy in immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Tuberculosis control in New York City--a changing landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin effects on the immune system: vitamins A and D take centre stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Serum 1,25-dihydroxyvitamin D: an outcome prognosticator in human sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Immunomodulatory effects of vitamin D on innate and adaptive immune responses to Streptococcus pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Murine CD8+ T cells but not macrophages express the vitamin D 1α-hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D deficiency in community-acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Cutting edge: Vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Immunophenotype of vitamin D receptor polymorphism associated to risk of HIV-1 infection and rate of disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Cell biology of mycobacterium tuberculosis phagosome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D induces interleukin-1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Association between vitamin D and hepatitis C virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

National estimates of severe sepsis in United States emergency departments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D3 induces autophagy of human myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Investigating the association between vitamin D deficiency and sepsis: challenges and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

The role of vitamin D deficiency in sepsis and potential therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Healthcare costs of methicillin resistant Staphylococcus aureus and Pseudomonas aeruginosa infections in veterans: role of vitamin D deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

Seasonal variation in the epidemiology of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

inferred from DOI database lookup

7 January 2021

based on heuristic

Severe vitamin D deficiency is associated with frequently observed diseases in medical inpatients

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352

inferred from DOI database lookup

7 January 2021

based on heuristic

Vitamin D, innate immunity and outcomes in community acquired pneumonia

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2014-0352